Healthcare provider profile · identity verified

Anne M Hirsch, MD

Internal Medicine · PORTLAND, OR · NPI 1407916513

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	399	115
Levothyroxine Sodium	Levothyroxine Sodium	358	101
Atorvastatin Calcium	Atorvastatin Calcium	348	105
Lisinopril	Lisinopril	283	73
Ezetimibe	Ezetimibe	277	89
Amlodipine Besylate	Amlodipine Besylate	248	71
Eliquis	Apixaban	182	43
Pravastatin Sodium	Pravastatin Sodium	179	52
Metformin Hcl Er	Metformin Hcl	176	56
Gabapentin	Gabapentin	175	56
Metoprolol Succinate	Metoprolol Succinate	173	50
Trazodone Hcl	Trazodone Hcl	137	40
Olmesartan Medoxomil	Olmesartan Medoxomil	136	38
Escitalopram Oxalate	Escitalopram Oxalate	131	44
Estradiol	Estradiol	128	49
Losartan Potassium	Losartan Potassium	126	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	121	41
Omeprazole	Omeprazole	120	42
Duloxetine Hcl	Duloxetine Hcl	119	30
Potassium Chloride	Potassium Chloride	116	35
Levoxyl	Levothyroxine Sodium	113	31
Synthroid	Levothyroxine Sodium	106	30
Zolpidem Tartrate	Zolpidem Tartrate	96	34
Bupropion Xl	Bupropion Hcl	95	27
Furosemide	Furosemide	90	30
Venlafaxine Hcl Er	Venlafaxine Hcl	87	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	83	23
Hydrochlorothiazide	Hydrochlorothiazide	82	23
Tramadol Hcl	Tramadol Hcl	74	22
Montelukast Sodium	Montelukast Sodium	73	21
Ozempic	Semaglutide	73	13
Alendronate Sodium	Alendronate Sodium	69	27
Albuterol Sulfate Hfa	Albuterol Sulfate	65	26
Alprazolam	Alprazolam	64	29
Carvedilol	Carvedilol	64	17
Oxycodone Hcl	Oxycodone Hcl	59	16
Pantoprazole Sodium	Pantoprazole Sodium	56	19
Nateglinide	Nateglinide	53	20
Allopurinol	Allopurinol	49	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	49	suppressed
Sertraline Hcl	Sertraline Hcl	49	16
Spironolactone	Spironolactone	49	12
Glimepiride	Glimepiride	47	13
Ondansetron Odt	Ondansetron	46	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	20
Fenofibric Acid	Fenofibric Acid (Choline)	44	13
Atenolol	Atenolol	43	11
Fentanyl	Fentanyl	43	suppressed
Farxiga	Dapagliflozin Propanediol	42	15
Fenofibrate	Fenofibrate,micronized	42	14
Diazepam	Diazepam	41	suppressed
Metformin Hcl	Metformin Hcl	41	13
Famotidine	Famotidine	40	12
Niacin Er	Niacin	40	12
Valsartan	Valsartan	40	11
Celecoxib	Celecoxib	39	13
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	11
Memantine Hcl	Memantine Hcl	37	suppressed
Minoxidil	Minoxidil	37	11
Triamcinolone Acetonide	Triamcinolone Acetonide	37	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Pregabalin	Pregabalin	36	suppressed
Progesterone	Progesterone, Micronized	36	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	21
Ramipril	Ramipril	35	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	34	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Colesevelam Hcl	Colesevelam Hcl	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	31	12
Acyclovir	Acyclovir	30	13
Azithromycin	Azithromycin	30	29
Donepezil Hcl	Donepezil Hcl	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	11
Metoprolol Tartrate	Metoprolol Tartrate	29	suppressed
Mirtazapine	Mirtazapine	29	11
Simvastatin	Simvastatin	29	suppressed
Folic Acid	Folic Acid	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	19
Prednisone	Prednisone	28	16
Lamotrigine	Lamotrigine	27	suppressed
Meloxicam	Meloxicam	27	14
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Entresto	Sacubitril/Valsartan	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Raloxifene Hcl	Raloxifene Hcl	25	suppressed
Lorazepam	Lorazepam	24	11
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	24	14
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	11
Premarin	Estrogens, Conjugated	23	11
Risperidone	Risperidone	23	suppressed
Liothyronine Sodium	Liothyronine Sodium	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Amoxicillin	Amoxicillin	19	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	18
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Colchicine	Colchicine	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Dicloxacillin Sodium	Dicloxacillin Sodium	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Teriparatide	Teriparatide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	11
Buspirone Hcl	Buspirone Hcl	12	suppressed
Finasteride	Finasteride	12	suppressed
Glyxambi	Empagliflozin/Linagliptin	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Mupirocin	Mupirocin	11	11
Nifedipine Er	Nifedipine	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error